Why the U.S. Is Running Behind With COVID-19 Vaccinations

Keith Speights, The Motley Fool
·6-min read

It's been over a month since Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) won U.S. emergency use authorization (EUA) for their COVID-19 vaccine. In this Motley Fool Live video recorded on Jan. 6, 2021, Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com writer Keith Speights discuss why the U.S. is running behind schedule with its vaccination rollouts. Corinne Cardina: Turning now to the US which of course has authorized those same two vaccines, one from Moderna, one from Pfizer-BioNTech.